Glimisave MV 3.3 F Tablet SR
Marketer
Eris Lifesciences Ltd
Salt Composition
Glimepiride (3mg) + Metformin (1000mg) + Voglibose (0.3mg)
Overview Glimisave MV 3.3 F Tablet SR
Diabetic patients utilizing the combination medication, Glimisave MV 3.3 F Tablet SR, should understand its anti-diabetic properties. This formulation manages type 2 diabetes in adults by regulating blood glucose. Consistent daily ingestion, ideally with meals, at the same time, maximizes effectiveness. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; premature discontinuation, without medical consultation, elevates blood sugar risk, potentially leading to complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, this drug complements a comprehensive diabetic management plan encompassing diet, exercise, and weight management as directed by your doctor. Commonly, Glimisave MV 3.3 F Tablet SR can cause hypoglycemia (low blood sugar). Learn to recognize its symptoms (sweating, dizziness, headache, trembling) and implement appropriate countermeasures, such as consuming readily available glucose (e.g., sugary foods, fruit juice). Alcohol consumption should be minimized due to its hypoglycemic risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease necessitates physician consultation before use. Pregnant or lactating individuals must seek medical advice. Regular blood glucose monitoring, along with periodic blood tests to evaluate blood cell counts and liver function, are recommended under your physician's guidance.
Primary Ingredients of Glimisave MV 3.3 F Tablet SR
The provided text is "undefined," which lacks meaning and cannot be rephrased. No rewriting is possible.
Uses of Glimisave MV 3.3 F Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimisave MV 3.3 F Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimisave MV 3.3 F Tablet SR whole; do not crush, chew, or divide it. Administer on an empty stomach.
Common Side effects of Glimisave MV 3.3 F Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimisave MV 3.3 F Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimisave MV 3.3 F Tablet SR on an empty stomach.
How Glimisave MV 3.3 F Tablet SR works:
Glimisave MV 3.3 F sustained-release tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimisave MV 3.3 F Tablet SR is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimisave MV 3.3 F Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Seek medical advice before using this medicine.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimisave MV 3.3 F Tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimisave MV 3.3 F Tablet SR is inadvisable for individuals with kidney impairment and should be strictly avoided. Patients with severe kidney disease are particularly cautioned against its use; physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Glimisave MV 3.3 F Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in severe cases.
What if you forget to take Glimisave MV 3.3 F Tablet SR :
Should you forget a dose of Glimisave MV 3.3 F Tablet SR, take it immediately if you remember. If, however, your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimisave MV 3.3 F Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently